BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10063270)

  • 1. T lymphocytes and cytokine production in ascitic fluid of ovarian malignancies.
    Chen CK; Wu MY; Chao KH; Ho HN; Sheu BC; Huang SC
    J Formos Med Assoc; 1999 Jan; 98(1):24-30. PubMed ID: 10063270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
    Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of the intracellular expression of interleukin 17 in patients with ovarian cancer].
    Rogala E; Nowicka A; Bednarek W; Barczyński B; Wertel I; Zakrzewski M; Kotarski J
    Ginekol Pol; 2012 Jun; 83(6):424-8. PubMed ID: 22880461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte subsets and cytokines in ascitic fluid of decompensated cirrhotic patients with and without spontaneous ascites infection.
    Kiyici M; Nak SG; Budak F; Gurel S; Oral B; Dolar E; Gulten M
    J Gastroenterol Hepatol; 2006 Jun; 21(6):963-9. PubMed ID: 16724979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells.
    Loercher AE; Nash MA; Kavanagh JJ; Platsoucas CD; Freedman RS
    J Immunol; 1999 Dec; 163(11):6251-60. PubMed ID: 10570318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascitic fluid-associated lymphocytes in patients with metastatic ovarian cancer. Analysis of lymphocyte subsets and of phenotypical changes induced by "in vitro".
    Loiudice L; Dell'Osso A; Loria MP; D'Ambra PP; Lasaracina E; Crollo E; Lucivero G
    Eur J Gynaecol Oncol; 1995; 16(4):301-6. PubMed ID: 7556288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood.
    Enríquez J; Klínger J; Arturo JA; Delgado M; Tobar C; Mosquera M
    Adv Perit Dial; 2002; 18():177-83. PubMed ID: 12402614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Without prior stimulation, tumor-associated lymphocytes from malignant effusions lyse autologous tumor cells in the presence of bispecific antibody HEA125xOKT3.
    Strauss G; Gückel B; Wallwiener D; Moldenhauer G
    Clin Cancer Res; 1999 Jan; 5(1):171-80. PubMed ID: 9918216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines in peritoneal fluid of ovarian neoplasms.
    de Lima CA; Silva Rodrigues IS; Martins-Filho A; Côbo Micheli D; Martins Tavares-Murta B; Candido Murta EF; Simões Nomelini R
    J Obstet Gynaecol; 2020 Apr; 40(3):401-405. PubMed ID: 31476946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
    Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.
    Moradi MM; Carson LF; Weinberg B; Haney AF; Twiggs LB; Ramakrishnan S
    Cancer; 1993 Oct; 72(8):2433-40. PubMed ID: 8402460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Leukocyte and lymphocyte populations in peripheral blood and malignant ascites in patients with ovarian carcinoma].
    Radke J; Schmidt D; Böhme M; Morenz J; Weise W
    Geburtshilfe Frauenheilkd; 1994 Dec; 54(12):675-8. PubMed ID: 7531661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
    Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
    Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phenotype of ascitic fluid lymphocytes in patients with ovarian carcinoma and other primaries.
    Melichar B; Tousková M; Tosner J; Kopecký O
    Onkologie; 2001 Apr; 24(2):156-60. PubMed ID: 11441296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphocytic subpopulations in malignant ascites of ovarian origin. Flow cytometric analysis].
    De Leonardis A; Casamassima A; Chiuri E; Addabbo L; De Frenza N; Falco G
    Minerva Ginecol; 1993 Jun; 45(6):291-300. PubMed ID: 8355884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis.
    Szyllo K; Tchorzewski H; Banasik M; Glowacka E; Lewkowicz P; Kamer-Bartosinska A
    Mediators Inflamm; 2003 Jun; 12(3):131-8. PubMed ID: 12857596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and qualitative peritoneal immune profiles, T-cell apoptosis and oxidative stress-associated characteristics in women with minimal and mild endometriosis.
    Mier-Cabrera J; Jiménez-Zamudio L; García-Latorre E; Cruz-Orozco O; Hernández-Guerrero C
    BJOG; 2011 Jan; 118(1):6-16. PubMed ID: 21083865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
    Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
    Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4⁺ CD25⁺ FOXP3⁺ regulatory T cells in peripheral blood and peritoneal fluid of patients with endometriosis.
    Olkowska-Truchanowicz J; Bocian K; Maksym RB; Białoszewska A; Włodarczyk D; Baranowski W; Ząbek J; Korczak-Kowalska G; Malejczyk J
    Hum Reprod; 2013 Jan; 28(1):119-24. PubMed ID: 23019301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.